Efficacy and safety of alirocumab in patients with hypercholesterolemia not adequately controlled with non-statin lipid-lowering therapy or the lowest strength of statin: ODYSSEY NIPPON study design and rationale
Tamio Teramoto,Akira Kondo,Arihiro Kiyosue…Volume:
16
Language:
english
Journal:
Lipids in Health and Disease
DOI:
10.1186/s12944-017-0513-7
Date:
December, 2017
File:
PDF, 469 KB
english, 2017